edoxaban
Term · Oncology and biomedicine · MLC-T-ONC-013209
An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is administered as edoxaban tosylate. This agent has an elimination half-life of 9-11 hours and undergoes renal excretion.
| Identifier | MLC-T-ONC-013209 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013209",
"term": "edoxaban",
"field": "Oncology and biomedicine",
"definition": "An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Edoxaban is administered as edoxaban tosylate. This agent has an elimination half-life of 9-11 hours and undergoes renal excretion.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/edoxaban/"
}
Record 6,377 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.